pharmaceutical — Online Journal — Columbia Undergraduate Law Review

Freedom to Innovate: The Paradox of Patentability in Pharmaceuticals Today

As a few of the many diagnostic companies that are pioneers of medical innovation in the modern age, these pharmaceutical businesses are rolling out new, precise drug therapies at an unprecedented rate to combat specific medical issues by introducing diagnostic methods based on new technologies. The current age of biotechnology continues to challenge lawmakers as innovation unfolds faster than the current existing protective legislature. But no legal issue is more prominent in the biotechnological industry than ownership rights to these new developments.

Kshithija MulamMay 24, 2019patents, pharmaceutical, medical, federalComment

Animal Science Products v. Hebei Welcome Pharmaceuticals - An Analysis

A major reappraisal of the U.S.-China trade relationship may have begun in the supplements aisle of your local health food store. The U.S. Supreme Court’s unanimous decision in Animal Science Products Inc. v. Hebei Welcome Pharmaceutical Co. 138 S. Ct. 1865 (2018) settled an international dispute spanning more than a decade over the sale of vitamin C supplements and the procedures for interpreting foreign law in U.S. federal courts.

Mark GyourkoApril 17, 2019EDNY, 2nd circuit, supreme court, rule 44.1, pharmaceutical, antitrustComment